JSB Market Research: PharmaPoint: Ulcerative Colitis - Global Drug Forecast and Market Analysis to 2022
During the forecast period from 2012-2022, the growth of the ulcerative colitis market will be driven largely by the entry of Johnson & Johnsons (J&Js) Simponi and Takedas Entyvio, which will lead to an increase in the overall number of patients being treated with biologics in the US, 5EU, Japan, and Canada. See More: http://goo.gl/tW6DQL
During the forecast period from 2012-2022, the growth of the ulcerative colitis market will be driven largely by the entry of Johnson & Johnsons (J&Js) Simponi and Takedas Entyvio, which will lead to an increase in the overall number of patients being treated with biologics in the US, 5EU, Japan, and Canada.
See More: http://goo.gl/tW6DQL
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
Reasons <strong>to</strong> buy<br />
• Develop <strong>and</strong> design in-licensing <strong>and</strong> out-licensing strategies through a review of<br />
pipeline products <strong>and</strong> technologies, <strong>and</strong> by identifying the companies with the<br />
most robust pipeline. Additionally a list of acquisition targets included in the<br />
pipeline product company list.<br />
• Develop business strategies by underst<strong>and</strong>ing the trends shaping <strong>and</strong> driving<br />
the global UC therapeutics markets.<br />
• Drive revenues by underst<strong>and</strong>ing the key trends, innovative products <strong>and</strong><br />
technologies, market segments, <strong>and</strong> companies likely <strong>to</strong> impact the global UC<br />
therapeutics markets in the future.<br />
• Formulate effective sales <strong>and</strong> marketing strategies by underst<strong>and</strong>ing the<br />
competitive l<strong>and</strong>scape <strong>and</strong> by analyzing the performance of various competi<strong>to</strong>rs.<br />
• Identify emerging players with potentially strong product portfolios <strong>and</strong> create<br />
effective counter-strategies <strong>to</strong> gain a competitive advantage.<br />
• Track drug sales in the global UC therapeutics markets from 2012-<strong>2022</strong>.<br />
• Organize sales <strong>and</strong> marketing efforts by identifying the market categories <strong>and</strong><br />
segments that present maximum opportunities for consolidations, investments<br />
<strong>and</strong> strategic partnerships.<br />
Table of Contents:<br />
1.1 List of Tables<br />
1.2 List of Figures<br />
2 Introduction 25<br />
2.1 Catalyst 25<br />
2.2 Related Reports 25<br />
Email ID- contact@jsbmarketresearch.com<br />
Tel No- 91 2241236650<br />
Published by- http:/www.jsbmarketresearch.com/
Change language